Table of Content

1 Report Overview
1.1 Peptide Antibiotics Definition
1.2 Market by Type
1.2.1 Global Peptide Antibiotics Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Ribosomal Synthesized Peptide Antibiotics
1.2.3 Non-Ribosomally Synthesized Peptide Antibiotics
1.3 Market Segment by Application
1.3.1 Global Peptide Antibiotics Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Pharma & Healthcare
1.3.3 Food Industry
1.3.4 Commodities
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Peptide Antibiotics Sales
2.1 Global Peptide Antibiotics Revenue Estimates and Forecasts 2018-2034
2.2 Global Peptide Antibiotics Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Peptide Antibiotics Revenue by Region
2.3.1 Global Peptide Antibiotics Revenue by Region (2018-2024)
2.3.2 Global Peptide Antibiotics Revenue by Region (2024-2034)
2.4 Global Peptide Antibiotics Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Peptide Antibiotics Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Peptide Antibiotics Sales Quantity by Region
2.6.1 Global Peptide Antibiotics Sales Quantity by Region (2018-2024)
2.6.2 Global Peptide Antibiotics Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Peptide Antibiotics Sales Quantity by Manufacturers
3.1.1 Global Peptide Antibiotics Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Peptide Antibiotics Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Peptide Antibiotics Sales in 2022
3.2 Global Peptide Antibiotics Revenue by Manufacturers
3.2.1 Global Peptide Antibiotics Revenue by Manufacturers (2018-2024)
3.2.2 Global Peptide Antibiotics Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Peptide Antibiotics Revenue in 2022
3.3 Global Peptide Antibiotics Sales Price by Manufacturers
3.4 Global Key Players of Peptide Antibiotics, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Peptide Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Peptide Antibiotics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Peptide Antibiotics, Product Offered and Application
3.8 Global Key Manufacturers of Peptide Antibiotics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Peptide Antibiotics Sales Quantity by Type
4.1.1 Global Peptide Antibiotics Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Peptide Antibiotics Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Peptide Antibiotics Sales Quantity Market Share by Type (2018-2034)
4.2 Global Peptide Antibiotics Revenue by Type
4.2.1 Global Peptide Antibiotics Historical Revenue by Type (2018-2024)
4.2.2 Global Peptide Antibiotics Forecasted Revenue by Type (2024-2034)
4.2.3 Global Peptide Antibiotics Revenue Market Share by Type (2018-2034)
4.3 Global Peptide Antibiotics Price by Type
4.3.1 Global Peptide Antibiotics Price by Type (2018-2024)
4.3.2 Global Peptide Antibiotics Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Peptide Antibiotics Sales Quantity by Application
5.1.1 Global Peptide Antibiotics Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Peptide Antibiotics Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Peptide Antibiotics Sales Quantity Market Share by Application (2018-2034)
5.2 Global Peptide Antibiotics Revenue by Application
5.2.1 Global Peptide Antibiotics Historical Revenue by Application (2018-2024)
5.2.2 Global Peptide Antibiotics Forecasted Revenue by Application (2024-2034)
5.2.3 Global Peptide Antibiotics Revenue Market Share by Application (2018-2034)
5.3 Global Peptide Antibiotics Price by Application
5.3.1 Global Peptide Antibiotics Price by Application (2018-2024)
5.3.2 Global Peptide Antibiotics Price Forecast by Application (2024-2034)
6 North America
6.1 North America Peptide Antibiotics Sales by Company
6.1.1 North America Peptide Antibiotics Revenue by Company (2018-2024)
6.1.2 North America Peptide Antibiotics Sales Quantity by Company (2018-2024)
6.2 North America Peptide Antibiotics Market Size by Type
6.2.1 North America Peptide Antibiotics Sales Quantity by Type (2018-2034)
6.2.2 North America Peptide Antibiotics Revenue by Type (2018-2034)
6.3 North America Peptide Antibiotics Market Size by Application
6.3.1 North America Peptide Antibiotics Sales Quantity by Application (2018-2034)
6.3.2 North America Peptide Antibiotics Revenue by Application (2018-2034)
6.4 North America Peptide Antibiotics Market Size by Country
6.4.1 North America Peptide Antibiotics Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Peptide Antibiotics Revenue by Country (2018-2034)
6.4.3 North America Peptide Antibiotics Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Peptide Antibiotics Sales by Company
7.1.1 Europe Peptide Antibiotics Sales Quantity by Company (2018-2024)
7.1.2 Europe Peptide Antibiotics Revenue by Company (2018-2024)
7.2 Europe Peptide Antibiotics Market Size by Type
7.2.1 Europe Peptide Antibiotics Sales Quantity by Type (2018-2034)
7.2.2 Europe Peptide Antibiotics Revenue by Type (2018-2034)
7.3 Europe Peptide Antibiotics Market Size by Application
7.3.1 Europe Peptide Antibiotics Sales Quantity by Application (2018-2034)
7.3.2 Europe Peptide Antibiotics Revenue by Application (2018-2034)
7.4 Europe Peptide Antibiotics Market Size by Country
7.4.1 Europe Peptide Antibiotics Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Peptide Antibiotics Revenue by Country (2018-2034)
7.4.3 Europe Peptide Antibiotics Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Peptide Antibiotics Sales by Company
8.1.1 China Peptide Antibiotics Sales Quantity by Company (2018-2024)
8.1.2 China Peptide Antibiotics Revenue by Company (2018-2024)
8.2 China Peptide Antibiotics Market Size by Type
8.2.1 China Peptide Antibiotics Sales Quantity by Type (2018-2034)
8.2.2 China Peptide Antibiotics Revenue by Type (2018-2034)
8.3 China Peptide Antibiotics Market Size by Application
8.3.1 China Peptide Antibiotics Sales Quantity by Application (2018-2034)
8.3.2 China Peptide Antibiotics Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Peptide Antibiotics Sales by Company
9.1.1 APAC Peptide Antibiotics Sales Quantity by Company (2018-2024)
9.1.2 APAC Peptide Antibiotics Revenue by Company (2018-2024)
9.2 APAC Peptide Antibiotics Market Size by Type
9.2.1 APAC Peptide Antibiotics Sales Quantity by Type (2018-2034)
9.2.2 APAC Peptide Antibiotics Revenue by Type (2018-2034)
9.3 APAC Peptide Antibiotics Market Size by Application
9.3.1 APAC Peptide Antibiotics Sales Quantity by Application (2018-2034)
9.3.2 APAC Peptide Antibiotics Revenue by Application (2018-2034)
9.4 APAC Peptide Antibiotics Market Size by Region
9.4.1 APAC Peptide Antibiotics Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Peptide Antibiotics Revenue by Region (2018-2034)
9.4.3 APAC Peptide Antibiotics Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Peptide Antibiotics Sales by Company
10.1.1 Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Peptide Antibiotics Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Peptide Antibiotics Market Size by Type
10.2.1 Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Peptide Antibiotics Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Peptide Antibiotics Market Size by Application
10.3.1 Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Peptide Antibiotics Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Peptide Antibiotics Market Size by Country
10.4.1 Middle East, Africa and Latin America Peptide Antibiotics Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Peptide Antibiotics Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Peptide Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Pfizer Peptide Antibiotics Products and Services
11.1.5 Pfizer Peptide Antibiotics SWOT Analysis
11.1.6 Pfizer Recent Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Overview
11.2.3 Novartis Peptide Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Novartis Peptide Antibiotics Products and Services
11.2.5 Novartis Peptide Antibiotics SWOT Analysis
11.2.6 Novartis Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline Peptide Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 GlaxoSmithKline Peptide Antibiotics Products and Services
11.3.5 GlaxoSmithKline Peptide Antibiotics SWOT Analysis
11.3.6 GlaxoSmithKline Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly Peptide Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Eli Lilly Peptide Antibiotics Products and Services
11.4.5 Eli Lilly Peptide Antibiotics SWOT Analysis
11.4.6 Eli Lilly Recent Developments
11.5 Theravance
11.5.1 Theravance Company Information
11.5.2 Theravance Overview
11.5.3 Theravance Peptide Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Theravance Peptide Antibiotics Products and Services
11.5.5 Theravance Peptide Antibiotics SWOT Analysis
11.5.6 Theravance Recent Developments
11.6 Vicuron Pharmaceuticals
11.6.1 Vicuron Pharmaceuticals Company Information
11.6.2 Vicuron Pharmaceuticals Overview
11.6.3 Vicuron Pharmaceuticals Peptide Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Vicuron Pharmaceuticals Peptide Antibiotics Products and Services
11.6.5 Vicuron Pharmaceuticals Peptide Antibiotics SWOT Analysis
11.6.6 Vicuron Pharmaceuticals Recent Developments
11.7 Savara Pharmaceuticals
11.7.1 Savara Pharmaceuticals Company Information
11.7.2 Savara Pharmaceuticals Overview
11.7.3 Savara Pharmaceuticals Peptide Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Savara Pharmaceuticals Peptide Antibiotics Products and Services
11.7.5 Savara Pharmaceuticals Peptide Antibiotics SWOT Analysis
11.7.6 Savara Pharmaceuticals Recent Developments
11.8 AMP Therapeutics
11.8.1 AMP Therapeutics Company Information
11.8.2 AMP Therapeutics Overview
11.8.3 AMP Therapeutics Peptide Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 AMP Therapeutics Peptide Antibiotics Products and Services
11.8.5 AMP Therapeutics Peptide Antibiotics SWOT Analysis
11.8.6 AMP Therapeutics Recent Developments
11.9 Hospira
11.9.1 Hospira Company Information
11.9.2 Hospira Overview
11.9.3 Hospira Peptide Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Hospira Peptide Antibiotics Products and Services
11.9.5 Hospira Peptide Antibiotics SWOT Analysis
11.9.6 Hospira Recent Developments
11.10 Kasten
11.10.1 Kasten Company Information
11.10.2 Kasten Overview
11.10.3 Kasten Peptide Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Kasten Peptide Antibiotics Products and Services
11.10.5 Kasten Peptide Antibiotics SWOT Analysis
11.10.6 Kasten Recent Developments
11.11 Madam Therapeutics
11.11.1 Madam Therapeutics Company Information
11.11.2 Madam Therapeutics Overview
11.11.3 Madam Therapeutics Peptide Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Madam Therapeutics Peptide Antibiotics Products and Services
11.11.5 Madam Therapeutics Recent Developments
11.12 Phosphagenics
11.12.1 Phosphagenics Company Information
11.12.2 Phosphagenics Overview
11.12.3 Phosphagenics Peptide Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Phosphagenics Peptide Antibiotics Products and Services
11.12.5 Phosphagenics Recent Developments
11.13 Pacgen Life Science Corporation
11.13.1 Pacgen Life Science Corporation Company Information
11.13.2 Pacgen Life Science Corporation Overview
11.13.3 Pacgen Life Science Corporation Peptide Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Pacgen Life Science Corporation Peptide Antibiotics Products and Services
11.13.5 Pacgen Life Science Corporation Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Peptide Antibiotics Value Chain Analysis
12.2 Peptide Antibiotics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Peptide Antibiotics Production Mode & Process
12.4 Peptide Antibiotics Sales and Marketing
12.4.1 Peptide Antibiotics Sales Channels
12.4.2 Peptide Antibiotics Distributors
12.5 Peptide Antibiotics Customers
13 Market Dynamics
13.1 Peptide Antibiotics Industry Trends
13.2 Peptide Antibiotics Market Drivers
13.3 Peptide Antibiotics Market Challenges
13.4 Peptide Antibiotics Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Peptide Antibiotics Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Ribosomal Synthesized Peptide Antibiotics
Table 3. Major Manufacturers of Non-Ribosomally Synthesized Peptide Antibiotics
Table 4. Global Peptide Antibiotics Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Peptide Antibiotics Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Peptide Antibiotics Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Peptide Antibiotics Revenue Market Share by Region (2018-2024)
Table 8. Global Peptide Antibiotics Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Peptide Antibiotics Revenue Market Share by Region (2024-2034)
Table 10. Global Peptide Antibiotics Sales Quantity by Region: 2018 VS 2022 VS 2034 (MT)
Table 11. Global Peptide Antibiotics Sales by Region (2018-2024) & (MT)
Table 12. Global Peptide Antibiotics Sales Market Share by Region (2018-2024)
Table 13. Global Peptide Antibiotics Sales by Region (2024-2034) & (MT)
Table 14. Global Peptide Antibiotics Sales Market Share by Region (2024-2034)
Table 15. Global Peptide Antibiotics Sales Quantity by Manufacturers (2018-2024) & (MT)
Table 16. Global Peptide Antibiotics Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Peptide Antibiotics Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Peptide Antibiotics Revenue Share by Manufacturers (2018-2024)
Table 19. Global Peptide Antibiotics Price by Manufacturers 2018-2024 (USD/Kg)
Table 20. Global Key Players of Peptide Antibiotics, Industry Ranking, 2021 VS 2022
Table 21. Global Peptide Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Peptide Antibiotics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Antibiotics as of 2022)
Table 23. Global Key Manufacturers of Peptide Antibiotics, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Peptide Antibiotics, Product Offered and Application
Table 25. Global Key Manufacturers of Peptide Antibiotics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Peptide Antibiotics Sales Quantity by Type (2018-2024) & (MT)
Table 28. Global Peptide Antibiotics Sales Quantity by Type (2024-2034) & (MT)
Table 29. Global Peptide Antibiotics Sales Quantity Share by Type (2018-2024)
Table 30. Global Peptide Antibiotics Sales Quantity Share by Type (2024-2034)
Table 31. Global Peptide Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Peptide Antibiotics Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Peptide Antibiotics Revenue Share by Type (2018-2024)
Table 34. Global Peptide Antibiotics Revenue Share by Type (2024-2034)
Table 35. Peptide Antibiotics Price by Type (2018-2024) & (USD/Kg)
Table 36. Global Peptide Antibiotics Price Forecast by Type (2024-2034) & (USD/Kg)
Table 37. Global Peptide Antibiotics Sales Quantity by Application (2018-2024) & (MT)
Table 38. Global Peptide Antibiotics Sales Quantity by Application (2024-2034) & (MT)
Table 39. Global Peptide Antibiotics Sales Quantity Share by Application (2018-2024)
Table 40. Global Peptide Antibiotics Sales Quantity Share by Application (2024-2034)
Table 41. Global Peptide Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Peptide Antibiotics Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Peptide Antibiotics Revenue Share by Application (2018-2024)
Table 44. Global Peptide Antibiotics Revenue Share by Application (2024-2034)
Table 45. Peptide Antibiotics Price by Application (2018-2024) & (USD/Kg)
Table 46. Global Peptide Antibiotics Price Forecast by Application (2024-2034) & (USD/Kg)
Table 47. North America Peptide Antibiotics Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Peptide Antibiotics Sales Quantity by Company (2018-2024) & (MT)
Table 49. North America Peptide Antibiotics Sales Quantity by Type (2018-2024) & (MT)
Table 50. North America Peptide Antibiotics Sales Quantity by Type (2024-2034) & (MT)
Table 51. North America Peptide Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Peptide Antibiotics Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Peptide Antibiotics Sales Quantity by Application (2018-2024) & (MT)
Table 54. North America Peptide Antibiotics Sales Quantity by Application (2024-2034) & (MT)
Table 55. North America Peptide Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Peptide Antibiotics Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Peptide Antibiotics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Peptide Antibiotics Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Peptide Antibiotics Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Peptide Antibiotics Sales Quantity by Country (2018-2024) & (MT)
Table 61. North America Peptide Antibiotics Sales Quantity by Country (2024-2034) & (MT)
Table 62. Europe Peptide Antibiotics Sales Quantity by Company (2018-2024) & (MT)
Table 63. Europe Peptide Antibiotics Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Peptide Antibiotics Sales Quantity by Type (2018-2024) & (MT)
Table 65. Europe Peptide Antibiotics Sales Quantity by Type (2024-2034) & (MT)
Table 66. Europe Peptide Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Peptide Antibiotics Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Peptide Antibiotics Sales Quantity by Application (2018-2024) & (MT)
Table 69. Europe Peptide Antibiotics Sales Quantity by Application (2024-2034) & (MT)
Table 70. Europe Peptide Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Peptide Antibiotics Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Peptide Antibiotics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Peptide Antibiotics Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Peptide Antibiotics Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Peptide Antibiotics Sales Quantity by Country (2018-2024) & (MT)
Table 76. Europe Peptide Antibiotics Sales Quantity by Country (2024-2034) & (MT)
Table 77. China Peptide Antibiotics Sales Quantity by Company (2018-2024) & (MT)
Table 78. China Peptide Antibiotics Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Peptide Antibiotics Sales Quantity by Type (2018-2024) & (MT)
Table 80. China Peptide Antibiotics Sales Quantity by Type (2024-2034) & (MT)
Table 81. China Peptide Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Peptide Antibiotics Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Peptide Antibiotics Sales Quantity by Application (2018-2024) & (MT)
Table 84. China Peptide Antibiotics Sales Quantity by Application (2024-2034) & (MT)
Table 85. China Peptide Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Peptide Antibiotics Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Peptide Antibiotics Sales Quantity by Company (2018-2024) & (MT)
Table 88. APAC Peptide Antibiotics Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Peptide Antibiotics Sales Quantity by Type (2018-2024) & (MT)
Table 90. APAC Peptide Antibiotics Sales Quantity by Type (2024-2034) & (MT)
Table 91. APAC Peptide Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Peptide Antibiotics Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Peptide Antibiotics Sales Quantity by Application (2018-2024) & (MT)
Table 94. APAC Peptide Antibiotics Sales Quantity by Application (2024-2034) & (MT)
Table 95. APAC Peptide Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Peptide Antibiotics Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Peptide Antibiotics Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Peptide Antibiotics Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Peptide Antibiotics Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Peptide Antibiotics Sales Quantity by Region (2018-2024) & (MT)
Table 101. APAC Peptide Antibiotics Sales Quantity by Region (2024-2034) & (MT)
Table 102. Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity by Company (2018-2024) & (MT)
Table 103. Middle East, Africa and Latin America Peptide Antibiotics Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity by Type (2018-2024) & (MT)
Table 105. Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity by Type (2024-2034) & (MT)
Table 106. Middle East, Africa and Latin America Peptide Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Peptide Antibiotics Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity by Application (2018-2024) & (MT)
Table 109. Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity by Application (2024-2034) & (MT)
Table 110. Middle East, Africa and Latin America Peptide Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Peptide Antibiotics Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Peptide Antibiotics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Peptide Antibiotics Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Peptide Antibiotics Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity by Country (2018-2024) & (MT)
Table 116. Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity by Country (2024-2034) & (MT)
Table 117. Pfizer Company Information
Table 118. Pfizer Description and Overview
Table 119. Pfizer Peptide Antibiotics Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 120. Pfizer Peptide Antibiotics Product and Services
Table 121. Pfizer Peptide Antibiotics SWOT Analysis
Table 122. Pfizer Recent Developments
Table 123. Novartis Company Information
Table 124. Novartis Description and Overview
Table 125. Novartis Peptide Antibiotics Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 126. Novartis Peptide Antibiotics Product and Services
Table 127. Novartis Peptide Antibiotics SWOT Analysis
Table 128. Novartis Recent Developments
Table 129. GlaxoSmithKline Company Information
Table 130. GlaxoSmithKline Description and Overview
Table 131. GlaxoSmithKline Peptide Antibiotics Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 132. GlaxoSmithKline Peptide Antibiotics Product and Services
Table 133. GlaxoSmithKline Peptide Antibiotics SWOT Analysis
Table 134. GlaxoSmithKline Recent Developments
Table 135. Eli Lilly Company Information
Table 136. Eli Lilly Description and Overview
Table 137. Eli Lilly Peptide Antibiotics Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 138. Eli Lilly Peptide Antibiotics Product and Services
Table 139. Eli Lilly Peptide Antibiotics SWOT Analysis
Table 140. Eli Lilly Recent Developments
Table 141. Theravance Company Information
Table 142. Theravance Description and Overview
Table 143. Theravance Peptide Antibiotics Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 144. Theravance Peptide Antibiotics Product and Services
Table 145. Theravance Peptide Antibiotics SWOT Analysis
Table 146. Theravance Recent Developments
Table 147. Vicuron Pharmaceuticals Company Information
Table 148. Vicuron Pharmaceuticals Description and Overview
Table 149. Vicuron Pharmaceuticals Peptide Antibiotics Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 150. Vicuron Pharmaceuticals Peptide Antibiotics Product and Services
Table 151. Vicuron Pharmaceuticals Peptide Antibiotics SWOT Analysis
Table 152. Vicuron Pharmaceuticals Recent Developments
Table 153. Savara Pharmaceuticals Company Information
Table 154. Savara Pharmaceuticals Description and Overview
Table 155. Savara Pharmaceuticals Peptide Antibiotics Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 156. Savara Pharmaceuticals Peptide Antibiotics Product and Services
Table 157. Savara Pharmaceuticals Peptide Antibiotics SWOT Analysis
Table 158. Savara Pharmaceuticals Recent Developments
Table 159. AMP Therapeutics Company Information
Table 160. AMP Therapeutics Description and Overview
Table 161. AMP Therapeutics Peptide Antibiotics Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 162. AMP Therapeutics Peptide Antibiotics Product and Services
Table 163. AMP Therapeutics Peptide Antibiotics SWOT Analysis
Table 164. AMP Therapeutics Recent Developments
Table 165. Hospira Company Information
Table 166. Hospira Description and Overview
Table 167. Hospira Peptide Antibiotics Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 168. Hospira Peptide Antibiotics Product and Services
Table 169. Hospira Peptide Antibiotics SWOT Analysis
Table 170. Hospira Recent Developments
Table 171. Kasten Company Information
Table 172. Kasten Description and Overview
Table 173. Kasten Peptide Antibiotics Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 174. Kasten Peptide Antibiotics Product and Services
Table 175. Kasten Peptide Antibiotics SWOT Analysis
Table 176. Kasten Recent Developments
Table 177. Madam Therapeutics Company Information
Table 178. Madam Therapeutics Description and Overview
Table 179. Madam Therapeutics Peptide Antibiotics Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 180. Madam Therapeutics Peptide Antibiotics Product and Services
Table 181. Madam Therapeutics Recent Developments
Table 182. Phosphagenics Company Information
Table 183. Phosphagenics Description and Overview
Table 184. Phosphagenics Peptide Antibiotics Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 185. Phosphagenics Peptide Antibiotics Product and Services
Table 186. Phosphagenics Recent Developments
Table 187. Pacgen Life Science Corporation Company Information
Table 188. Pacgen Life Science Corporation Description and Overview
Table 189. Pacgen Life Science Corporation Peptide Antibiotics Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 190. Pacgen Life Science Corporation Peptide Antibiotics Product and Services
Table 191. Pacgen Life Science Corporation Recent Developments
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Peptide Antibiotics Distributors List
Table 195. Peptide Antibiotics Customers List
Table 196. Peptide Antibiotics Market Trends
Table 197. Peptide Antibiotics Market Drivers
Table 198. Peptide Antibiotics Market Challenges
Table 199. Peptide Antibiotics Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Antibiotics Product Picture
Figure 2. Global Peptide Antibiotics Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Peptide Antibiotics Market Share by Type in 2022 & 2034
Figure 4. Ribosomal Synthesized Peptide Antibiotics Product Picture
Figure 5. Non-Ribosomally Synthesized Peptide Antibiotics Product Picture
Figure 6. Global Peptide Antibiotics Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Peptide Antibiotics Market Share by Application in 2022 & 2034
Figure 8. Pharma & Healthcare
Figure 9. Food Industry
Figure 10. Commodities
Figure 11. Other
Figure 12. Peptide Antibiotics Report Years Considered
Figure 13. Global Peptide Antibiotics Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Peptide Antibiotics Revenue 2018-2034 (US$ Million)
Figure 15. Global Peptide Antibiotics Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Peptide Antibiotics Sales Quantity 2018-2034 (MT)
Figure 17. Global Peptide Antibiotics Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global Peptide Antibiotics Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Peptide Antibiotics Sales Quantity YoY (2018-2034) & (MT)
Figure 20. North America Peptide Antibiotics Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Peptide Antibiotics Sales Quantity YoY (2018-2034) & (MT)
Figure 22. Europe Peptide Antibiotics Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Peptide Antibiotics Sales Quantity YoY (2018-2034) & (MT)
Figure 24. China Peptide Antibiotics Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Peptide Antibiotics Sales Quantity YoY (2018-2034) & (MT)
Figure 26. APAC Peptide Antibiotics Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity YoY (2018-2034) & (MT)
Figure 28. Middle East, Africa and Latin America Peptide Antibiotics Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Peptide Antibiotics Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by Peptide Antibiotics Revenue in 2022
Figure 31. Peptide Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Peptide Antibiotics Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Peptide Antibiotics Revenue Market Share by Type (2018-2034)
Figure 34. Global Peptide Antibiotics Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Peptide Antibiotics Revenue Market Share by Application (2018-2034)
Figure 36. North America Peptide Antibiotics Revenue Market Share by Company in 2022
Figure 37. North America Peptide Antibiotics Sales Quantity Market Share by Company in 2022
Figure 38. North America Peptide Antibiotics Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Peptide Antibiotics Revenue Market Share by Type (2018-2034)
Figure 40. North America Peptide Antibiotics Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Peptide Antibiotics Revenue Market Share by Application (2018-2034)
Figure 42. North America Peptide Antibiotics Revenue Share by Country (2018-2034)
Figure 43. North America Peptide Antibiotics Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Peptide Antibiotics Sales Quantity Market Share by Company in 2022
Figure 47. Europe Peptide Antibiotics Revenue Market Share by Company in 2022
Figure 48. Europe Peptide Antibiotics Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Peptide Antibiotics Revenue Market Share by Type (2018-2034)
Figure 50. Europe Peptide Antibiotics Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Peptide Antibiotics Revenue Market Share by Application (2018-2034)
Figure 52. Europe Peptide Antibiotics Revenue Share by Country (2018-2034)
Figure 53. Europe Peptide Antibiotics Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 55. France Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 59. China Peptide Antibiotics Sales Quantity Market Share by Company in 2022
Figure 60. China Peptide Antibiotics Revenue Market Share by Company in 2022
Figure 61. China Peptide Antibiotics Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Peptide Antibiotics Revenue Market Share by Type (2018-2034)
Figure 63. China Peptide Antibiotics Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Peptide Antibiotics Revenue Market Share by Application (2018-2034)
Figure 65. APAC Peptide Antibiotics Sales Quantity Market Share by Company in 2022
Figure 66. APAC Peptide Antibiotics Revenue Market Share by Company in 2022
Figure 67. APAC Peptide Antibiotics Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Peptide Antibiotics Revenue Market Share by Type (2018-2034)
Figure 69. APAC Peptide Antibiotics Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Peptide Antibiotics Revenue Market Share by Application (2018-2034)
Figure 71. APAC Peptide Antibiotics Revenue Share by Region (2018-2034)
Figure 72. APAC Peptide Antibiotics Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 77. India Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Peptide Antibiotics Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Peptide Antibiotics Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Peptide Antibiotics Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Peptide Antibiotics Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Peptide Antibiotics Revenue Share by Country (2018-2034)
Figure 86. Brazil Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Peptide Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 91. Peptide Antibiotics Value Chain
Figure 92. Peptide Antibiotics Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed